Mayne Pharma Group Limited (ASX:MYX)
Australia · Delayed Price · Currency is AUD 2.810
-0.140 (-4.75%)
Sep 25, 2026, 4:10 PM AEST
Mayne Pharma Group Revenue
In the fiscal year ending June 30, 2026, Mayne Pharma Group had annual revenue of 383.68M AUD, down -5.98%. Mayne Pharma Group had revenue of 171.61M in the half year ending June 30, 2026, a decrease of -14.40%.
Revenue
383.68M
Revenue Growth
-5.98%
P/S Ratio
0.60
Revenue / Employee
1.06M
Employees
363
Market Cap
228.30M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 383.68M | -24.42M | -5.98% |
| Jun 30, 2025 | 408.10M | 19.70M | 5.07% |
| Jun 30, 2024 | 388.40M | 204.81M | 111.56% |
| Jun 30, 2023 | 183.59M | 26.44M | 16.82% |
| Jun 30, 2022 | 157.15M | -243.63M | -60.79% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 22.83B |
| Ramsay Health Care | 18.58B |
| Sigma Healthcare | 10.83B |
| Paragon Care | 3.68B |
| Healius | 1.37B |
| Monash IVF Group | 269.46M |
| Pro Medicus | 261.69M |
| BLS Pharmaceuticals | 73.91M |
Mayne Pharma Group News
- 4 weeks ago - Mayne Pharma Group Earnings Call Transcript: H2 2026 - Transcripts
- 4 weeks ago - Mayne Pharma Group Annual report: H2 2026 - Filings
- 4 weeks ago - Mayne Pharma Group Earnings release: H2 2026 - Filings
- 4 weeks ago - Mayne Pharma Group Slides: H2 2026 - Filings
- 7 weeks ago - Mayne Pharma investors push for break-up after blocked takeover bid - The Australian Financial Review
- 4 months ago - Mayne Pharma Group Slides: Investor presentation - Filings
- 6 months ago - Mayne Pharma Group Transcript: ASX Small Caps Conference 2026 - Transcripts
- 6 months ago - Mayne Pharma Group Transcript: Investor update - Transcripts